ChiCTR2400086618 版本V1.0 版本创建时间2024/07/08 09:51:22 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2400086618 

最近更新日期:

Date of Last Refreshed on:

2024-07-08 09:51:14 

注册时间:

Date of Registration:

2024-07-08 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

新生儿急性呼吸窘迫综合征

Public title:

neonate acute respiratory distress syndrome

注册题目简写:

English Acronym:

研究课题的正式科学名称:

羊水污染新生儿急性呼吸窘迫综合征危险因素分析及风险评分系统模型构建

Scientific title:

Establishment and evaluation of nomogram for predicting acute respiratory distress syndrome in meconium-stained amniotic fluid neonates

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

沈蕾蕾 

研究负责人:

沈蕾蕾 

Applicant:

Shenleilei 

Study leader:

Shenleilei 

申请注册联系人电话:

Applicant telephone:

+86 13320294100

研究负责人电话:

Study leader's telephone:

+86 13320294100

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

aa_sll@163.com

研究负责人电子邮件:

Study leader's E-mail:

aa_sll@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

重庆市沙坪坝区高滩岩正街30号

研究负责人通讯地址:

重庆市沙坪坝区高滩岩正街29号

Applicant address:

30 Gaotan Yan Zheng Street, Shapingba District, Chongqing City

Study leader's address:

No 29 Gaotanyan Main Street Shapingba District Chongqing

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

陆军军医大学第一附属医院

Applicant's institution:

Army Medical University First Affiliated Hospital

研究负责人所在单位:

中国人民解放军陆军军医大学第一附属医院

Affiliation of the Leader:

The First Affiliated Hospital of Army Medical University

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

(B)KY2024172

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

中国人民解放军陆军军医大学第一附属医院伦理委员会

Name of the ethic committee:

Ethics Committee of the First Affiliated Hospital of Army Medical University PLA

伦理委员会批准日期:

Date of approved by ethic committee:

2024-05-24 00:00:00

伦理委员会联系人:

贺莉

Contact Name of the ethic committee:

He Li

伦理委员会联系地址:

重庆市沙坪坝区高滩岩正街29号

Contact Address of the ethic committee:

No 29 Gaotanyan Main Street Shapingba District Chongqing

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 23 68754035

伦理委员会联系人邮箱:

Contact email of the ethic committee:

cqhl13@qq.com

研究实施负责(组长)单位:

中国人民解放军陆军军医大学第一附属医院

Primary sponsor:

The First Affiliated Hospital of Army Medical University

研究实施负责(组长)单位地址:

重庆市沙坪坝区高滩岩正街29号

Primary sponsor's address:

No 29 Gaotanyan Main Street Shapingba District Chongqing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

重庆

市(区县):

Country:

China

Province:

Chongqing

City:

单位(医院):

中国人民解放军陆军军医大学第一附属医院

具体地址:

重庆市沙坪坝区高滩岩正街29号

Institution
hospital:

The First Affiliated Hospital of Army Medical University

Address:

No 29 Gaotanyan Main Street Shapingba District Chongqing

经费或物资来源:

Source(s) of funding:

no

Target disease:

naonate acute respiratory distress syndrome

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

队列研究 

Study design:

Cohort study 

研究目的:

探讨暴露于污染羊水(MSAF)的新生儿急性呼吸窘迫综合征(ARDS)的危险因素并建立预测列线图。  

Objectives of Study:

To delineate risk factors and develop a predictive nomogram for acute respiratory distress syndrome (ARDS) in neonates exposed to meconium-stained amniotic fluid (MSAF).

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1. ARDS组 ① 2019年01月01日—2024年01月01日入住我科NICU患病新生儿; ② 产时羊水污染; ③ 符合“蒙特勒标准”; 2. 非ARDS组 ① 2019年01月01日—2024年01月01日入住我科NICU患病新生儿; ② 产时羊水污染; ③ 未达到“蒙特勒标准”诊断要求;

Inclusion criteria

1. ARDS group ① Sick neonates admitted to our NICU from 01/01/2019 - 01/01/2024; ② Amniotic fluid contamination during labor; ③ Compliance with "Montreux definition"; 2. non-ARDS group ① Sick neonates admitted to our NICU from 01/01/2019 - 01/01/2024; ② Amniotic fluid contamination during labor; ③ Failure to meet the diagnostic requirements of the "Montreux Definition";

排除标准:

① 产时羊水污染; ② 确诊为其他疾病(TTN、RDS); ③ 外科或发育异常原因所导致的呼吸窘迫,如:气胸、膈疝、先天性肺畸形等。

Exclusion criteria:

① Amniotic fluid contamination during labor; ② Diagnosed with other diseases(TTNRDS); ③ Respiratory distress due to surgical or developmental abnormalities, e.g., pneumothorax, diaphragmatic hernia, congenital lung malformations, etc.

研究实施时间:

Study execute time:

From 2024-07-10 00:00:00 To 2024-09-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-07-12 00:00:00 To 2024-08-25 00:00:00  

干预措施:

Interventions:

组别:

ARDS组 产时羊水污染

样本量:

91

Group:

ARDS group Meconium-stained amniotic fluid

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

组别:

非ARDS组 产时羊水污染

样本量:

155

Group:

non-ARDS group Meconium-stained amniotic fluid

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

重庆 

市(区县):

 

Country:

China 

Province:

Chongqing 

City:

 

单位(医院):

中国人民解放军陆军军医大学第一附属医院 

单位级别:

三级甲等 

Institution
hospital:

The First Affiliated Hospital of Army Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

人口统计学特性(性别、胎龄、体重、单双胎等)

指标类型:

次要指标

Outcome:

demographic characteristics (sex, gestational age, weight, singleton and twin births, etc.)

Type:

Secondary indicator

测量时间点:

入院时

测量方法:

临床记录

Measure time point of outcome:

At admission

Measure method:

clinography

指标中文名:

母亲孕期合并症情况(妊娠期糖尿病、妊娠期高血压、妊娠期胆汁淤积症)

指标类型:

次要指标

Outcome:

maternal comorbidities during pregnancy (gestational diabetes mellitus, gestational hypertension, gestational cholestasis)

Type:

Secondary indicator

测量时间点:

入院时

测量方法:

临床记录

Measure time point of outcome:

At admission

Measure method:

clinography

指标中文名:

母亲产前情况(是否提前破膜,产前是否使用激素)

指标类型:

次要指标

Outcome:

The mother’s prenatal status (whether the membranes were ruptured in advance, whether hormones were used before delivery)

Type:

Secondary indicator

测量时间点:

入院时

测量方法:

临床记录

Measure time point of outcome:

At admission

Measure method:

clinography

指标中文名:

血生化及影像学检查

指标类型:

主要指标

Outcome:

Blood biochemistry and imaging examinations

Type:

Primary indicator

测量时间点:

生后3天内

测量方法:

化验检查

Measure time point of outcome:

Within 3 days of birth

Measure method:

laboratory examination

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

NA

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 0 years
最大 Max age 1 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

不共享

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

no

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病历记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Medical record sheet

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2024-07-08 09:51:14